Skyhawk Appoints Aaron Deves as Chief Commercial Officer to Lead Commercialization of SKY-0515 for Huntington’s Disease
Industry veteran brings more than 30 years of experience launching therapies for neurological diseases, including Huntington’s disease, and will prepare…